SEC Form 4 · accession 0001209191-16-119377
aTYR PHARMA INC · LIFE
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Grove Matsuoka
Officer — See Remarks
Period of report
May 9, 2016
Accepted (ET)
May 11, 2016 · 8:54 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001339970
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | May 9, 2016 | P | 2,412 | $3.08 | A | 2,412 | D | |
| Common Stock | May 11, 2016 | P | 10,000 | $3.03 | A | 12,412 | D |
Table II — derivative securities
No Table II lines on this filing.
Remarks
Senior Vice President, Product Programs & Planning